During the past decade, Millennium Oncology conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 23 clinical trials were completed, i.e. on average, 71.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 14 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Millennium Oncology" #1 sponsor was "Celgene" with 7 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "G1 Therapeutics, Inc." with 3 trials sponsored, "Genprex, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Millennium Oncology" #1 collaborator was "ARMO BioSciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Millennium Oncology" are "Breast Cancer" (4 trials), "Non Small Cell Lung Cancer" (4 trials), "Multiple Myeloma" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Millennium Oncology" in a lesser frequency.

Most popular intervention types in "Millennium Oncology" are "Drug" (35 trials), "Biological" (8 trials), "Other" (3 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Docetaxel" (4 trials), "Nivolumab" (4 trials), "Pembrolizumab" (3 trials) and "Rituximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Millennium Oncology" are 34 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Millennium Oncology". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Millennium Oncology, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Millennium Oncology, 6 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Millennium Oncology has several departments that took part in Clinical trials: "Millennium Oncology" - 2 trials, "Renovatio Clinical-Respiratory & Sleep Disorders Specialists" - 2 trials